Abstract
SummaryNormal sera do not inhibit the grossly visible clot formed by addition of hex-amminecobaltic chloride to aqueous solutions of calf thymus DNA. The sera of approximately 66% of patients with DLE inhibit such clot formation. Prior treatment of DNA by active DNase also prevents clot formation, as does addition of histone or protamine to normal sera. The serum factor responsible for such inhibition is removed by prior incubation with whole calf thymus or guinea pig nuclei.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
